{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:05:18Z","timestamp":1793858718523,"version":"4.6.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/gme.0b013e31819e8e2d","type":"journal-article","created":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T03:14:00Z","timestamp":1251515640000},"page":"907-922","source":"Crossref","is-referenced-by-count":158,"title":["Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy"],"prefix":"10.1097","volume":"16","author":[{"given":"Fernand","family":"Labrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonello","family":"Cusan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Luis","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Normand","family":"Ayotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyne","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Balser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20210227","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/gme.0b013e31805170eb","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 Position Statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R3-15-20210227","first-page":"228","article-title":"Postmenopausal vaginal atrophy and atrophic vaginitis.","volume":"314","author":"Pandit","year":"1997","journal-title":"Am J Med Sci"},{"key":"R4-15-20210227","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer.","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"R5-15-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R6-15-20210227","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/01.AOG.0000241091.86268.6e","article-title":"Breast cancer risk in postmenopausal women using estrogen-only therapy.","volume":"108","author":"Lyytinen","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R7-15-20210227","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/annonc\/mdm404","article-title":"Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.","volume":"19","author":"Corrao","year":"2008","journal-title":"Ann Oncol"},{"key":"R8-15-20210227","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R9-15-20210227","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1055-9965.EPI-07-0713","article-title":"A common 8q24 variant and the risk of colon cancer: a population-based case-control study.","volume":"17","author":"Li","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-15-20210227","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"R11-15-20210227","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/94.7.497","article-title":"Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.","volume":"94","author":"Riman","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R12-15-20210227","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.","volume":"285","author":"Rodriguez","year":"2001","journal-title":"JAMA"},{"key":"R13-15-20210227","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis.","volume":"85","author":"Grady","year":"1995","journal-title":"Obstet Gynecol"},{"key":"R14-15-20210227","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","article-title":"Endometrial cancer and hormone-replacement therapy in the Million Women Study.","volume":"365","author":"Beral","year":"2005","journal-title":"Lancet"},{"key":"R15-15-20210227","first-page":"159","article-title":"Drospirenone-containing hormone therapy for postmenopausal women. Perspective on current data.","volume":"52","author":"Archer","year":"2007","journal-title":"J Reprod Med"},{"key":"R16-15-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17-Estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"R17-15-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1447-0756.2001.tb01266.x","article-title":"The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.","volume":"27","author":"Manonai","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"R18-15-20210227","first-page":"556","article-title":"Estradiol absorption from vaginal tablets in postmenopausal women.","volume":"99","author":"Notelovitz","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R19-15-20210227","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.ejca.2005.07.015","article-title":"Vaginal oestrogen therapy after breast cancer: is it safe?","volume":"41","author":"Ponzone","year":"2005","journal-title":"Eur J Cancer"},{"key":"R20-15-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"key":"R21-15-20210227","first-page":"85","article-title":"Estrogen effects on the vaginal pH, flora and cytology in late postmenopause after a long period without hormone therapy.","volume":"33","author":"Galhardo","year":"2006","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R22-15-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R23-15-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.gme.0000227401.98933.0b","article-title":"A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women.","volume":"13","author":"Long","year":"2006","journal-title":"Menopause"},{"key":"R24-15-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.AOG.0000296714.12226.0f","article-title":"Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.","volume":"111","author":"Bachmann","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R25-15-20210227","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/bcr1378","article-title":"Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.","volume":"8","author":"Rosenberg","year":"2006","journal-title":"Breast Cancer Res"},{"key":"R26-15-20210227","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e31817b6132","article-title":"Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"R27-15-20210227","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocr Rev"},{"key":"R28-15-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ncpendmet0559","article-title":"Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.","volume":"3","author":"Labrie","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R29-15-20210227","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.","volume":"99","author":"Labrie","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R30-15-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2005.02.018","article-title":"Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina.","volume":"96","author":"Berger","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R31-15-20210227","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0960-0760(98)00052-1","article-title":"Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat.","volume":"66","author":"Sourla","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R32-15-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jsbmb.2008.09.007","article-title":"Corrigendum to: effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.","volume":"112","author":"Labrie","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R33-15-20210227","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2008.06.003","article-title":"Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.","volume":"111","author":"Labrie","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R34-15-20210227","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jcem.82.10.4306","article-title":"Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.","volume":"82","author":"Labrie","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-15-20210227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2008.02.003","article-title":"Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.","volume":"110","author":"Labrie","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R36-15-20210227","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2006.09.034","article-title":"Metabolism of DHEA in postmenopausal women following percutaneous administration.","volume":"103","author":"Labrie","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R37-15-20210227","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/gme.0b013e31819e8930","article-title":"Serum steroid levels during 12-week intravaginal DHEA administration.","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"R38-15-20210227","first-page":"249","article-title":"The maturation value.","volume":"11","author":"Meisels","year":"1967","journal-title":"Acta Cytol"},{"key":"R39-15-20210227","first-page":"358","article-title":"Industrial developments in automated cytology as submitted by their developers.","volume":"15","author":"Wied","year":"1993","journal-title":"Anal Quant Cytol Histol"},{"key":"R40-15-20210227","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"R41-15-20210227","first-page":"45","article-title":"Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.","volume":"10","author":"Pinkerton","year":"2003","journal-title":"Menopause"},{"key":"R42-15-20210227","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"R43-15-20210227","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women.","volume":"18","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R44-15-20210227","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology.","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"R46-15-20210227","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/endo-123-3-1412","article-title":"Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.","volume":"123","author":"Labrie","year":"1988","journal-title":"Endocrinology"},{"key":"R47-15-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.1.06264","article-title":"Is DHEA a hormone? Starling review.","volume":"187","author":"Labrie","year":"2005","journal-title":"J Endocrinol"},{"key":"R48-15-20210227","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2006.03.006","article-title":"DHEA is an anabolic steroid like testosterone and THG.","volume":"100","author":"Labrie","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R49-15-20210227","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/er.2004-0017","article-title":"GnRH agonists in the treatment of prostate cancer.","volume":"26","author":"Labrie","year":"2005","journal-title":"Endocr Rev"},{"key":"R50-15-20210227","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2007.07.1359","article-title":"Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.","volume":"90","author":"Simon","year":"2008","journal-title":"Fertil Steril"},{"key":"R51-15-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0020-7292(03)00200-5","article-title":"Local estrogen treatment in patients with urogenital symptoms.","volume":"82","author":"Simunic","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"R52-15-20210227","first-page":"12","article-title":"Long-term non-hormonal treatment of vagina dryness.","volume":"8","author":"Bachmann","year":"1992","journal-title":"J Clin Pract Sex"},{"key":"R53-15-20210227","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-4731(81)90140-0","article-title":"Inability of human endometrium or myometrium to aromatize androstenedione.","volume":"14","author":"Baxendale","year":"1981","journal-title":"J Steroid Biochem"},{"key":"R54-15-20210227","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.57.3.6","article-title":"Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.","volume":"57","author":"Bulun","year":"2005","journal-title":"Pharmacol Rev"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200916050-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:05:51Z","timestamp":1786039551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200916050-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31819e8e2d","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}